Direct-to-consumer prescription drug advertising builds bridges between patients and physicians

JAMA

Volumn 281, Issue 4, 1999, Pages 380-382

  Holmer, Alan F ^a  

^a Pharmaceutical Res Manufacturers A   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERTIZING; CONSUMER; DRUG MARKETING; FOOD AND DRUG ADMINISTRATION; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0033608189     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.281.4.380     Document Type: Short Survey

References (21)

1. Nordenberg T. Direct to you: TV drug ads that make sense. FDA Consumer. January-February 1998;32:7-10.
2. Kodysz M, Bower BA. Medical sites on the Internet continue to proliferate. Mod Med. May 1998;66:56.
3. Prevention Magazine. National Survey of Consumer Reactions to Direct-to-Consumer Advertising. Emmaus, Pa: Rodale Press; 1998.
4. IMS reports pharmaceutical promotions rose 16% in 1997 [press release]. Plymouth Meeting, Pa: IMS HEALTH; March 31, 1998.
5. American Diabetes Association: Clinical Practice Recommendations 1997. Diabetes Care. 1997; 20(suppl 1):S1-S70.
6. Pill pushers. Economist. August 8, 1997;344(8029):58-59.
7. Hirschfeld RM, Keller MB, Panico S, et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA. 1997;277:333-334.
8. National Health and Nutrition Examination Survey. Washington, DC: National Center for Health Statistics; 1988-1994.
9. Avorn J, Monette J, Lacour A, et al. Persistence of use of lipid-lowering medications: a cross-national study. JAMA. 1998;279:1458-1462.
10. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. JAMA. 1998;279:1615-1622.
11. Secondary and Tertiary Prevention of Stroke Patient Outcome Research Team: 9th Progress Report, March 1996. Rockville, Md: Agency for Health Care Policy and Research; 1996.
12. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarcation. N Engl J Med. 1998; 339:489-497
13. Krumholz HM, Radford MJ, Wang Y, Chen J, Heiat A, Marciniak TA. National use and effectiveness of β-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA. 1998;280:623-629.
14. DTC ads prompted prescriptions for 7.5 million Americans, AphA/Prevention survey concludes. F-D-C Reports-The Pink Sheet. October 20, 1997;59 (42):9-10.
15. National Disease and Therapeutic Index [database online]. Plymouth Meeting, Pa: IMS HEALTH; 1996.
16. Tanouye E. Drug ads spur patients to demand more prescriptions. Wall Street Journal. December 22, 1997;B1.
17. Executive summary. In: A Survey of the Patient-Physician Relationship to America. Norwalk, Conn: Yankelovich Partners Inc; April 1998:4.
18. Ventura SJ, Anderson RN, Martin JA, Smith BL. Births and Deaths: Preliminary Data for 1997, National Vital Statistics Reports [vol 47, No. 4]. Hyattsville, Md: National Center for Health Statistics; 1998:1.
19. Hunink MGM, Goldman L, Tosteson ANA, et al. The recent decline in mortality from coronary heart disease, 1980-1990: the effect of secular trends in risk factors and treatment. JAMA. 1997;277:535-542.
20. Peters KD, Kochaneck KD, Murphy SL. Deaths: Final Data for 1996: National Vital Statistics Reports [vol 47, No. 9]. Hyattsville, Md: National Center for Health Statistics, 1998:52.
21. Pharmaceutical Research and Manufacturers of America (PhRMA). New Medicines in Development Database. Available at: http://www.phrma.org/webdb/ phrmawdb.html. Accessed December 1, 1998.